Home Industries Market Insights About Us Publisher Contact us

Artificial Intelligence in Medical Diagnostics Market By Constituent Type (Software, Hardware), By AI Type (Reactive Machines, Artificial Narrow Intelligence (ANI), Artificial General Intelligence (AGI), Artificial Super Intelligence (ASI), Others), By Application (Diagnosing techniques, Ultrasound, MRI (= Magnetic Resonance Imaging), CT (= Computed Tomography), X-Ray, Diagnosing fields, Oncology, Ophthalmology, Neurology, Others) End User (Hospitals, Diagnostic Facilities, Research and Development Laboratories) - Global Opportunity Analysis And Industry Forecast, 2021-2027

Categories: Life Science

Formate :

Global Artificial Intelligence in Medical Diagnostics Market Overview

The Global Artificial Intelligence in Medical Diagnostics market size is estimated to reach $3,946 million by 2026, growing at a CAGR of 31.7% over the forecast period of 2021-2026. Artificial Intelligence (AI) can be delineated as a technology in which a machine or computer-controlled by another computer does tasks frequently executed by human beings. It's quite a contemporary concept that is expected to revolutionize our society completely as it extends countless benefits from e-commerce to the medical sector through the automation of processes.

Its role has been spiked in the medical diagnostic field as the whole world is witnessing unprecedented prevalence in life-threatening conditions such as Herat attack and cancer. Therefore, the demand for state-of-the-art AI-associated diagnostic techniques, including many imaging facilities like Computed Tomography, Optical Coherence Technology, and Magnetic Resonance Imaging, is of phenomenal help in spotting and treating such problems with care. Rising jaw-dropping breakthroughs in technology and elevation in life-threatening chronic maladies are factors set to drive the growth of Artificial Intelligence (AI) in the Medical Diagnostics Market.

 

Impact of COVID-19:

COVID-19 had a positive impact on the market as post-COVID-19 priorities of people around the globe have changed so of the governments. Governments are attentive to refining the healthcare infrastructure in their respective countries like never before. Governments worldwide increased the country's health spending by almost 110% to tackle upcoming contingencies. Moreover, per capita, healthcare spending of ASEAN nation Vietnam reached $18 billion in 2021 and is estimated to reach $25-26 billion in the foreseeable future. Furthermore, more riches in research are ensuing into several breakthroughs, ultimately fueling the demand for the market as mentioned above.

 

Key Takeaways from Global Artificial Intelligence in Medical Diagnostics Market Report 

·   Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units), and Value ($M) data given at country level – for Constituent type, AI Type, Application, End-user, and by different industry verticals.

·   Understand the different market dynamics – key driving factors, challenges, and hidden opportunities.

·   Get in-depth insights on your competitor's performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT, and more.

·   Analyze the sales and distribution channels across key geographies to improve top-line revenues.

·   Understand the industry supply chain with a deep dive on the value augmentation at each step to optimize value and bring efficiencies in your processes.

·   Get a quick outlook on the market entropy – M&As, deals, partnerships, product launches of all key players for the past four years.

·   Evaluate the supply-demand gaps, import-export statistics, and regulatory landscape for more than the top 20 countries globally for the market.

 Artificial Intelligence in Medical Diagnostics Market

By Application, the market for Radiology and Oncology segments to grow at the highest CAGR during the forecast period

During the forecast period, the market for radiology and oncology segments is predicted to develop at the fastest rate of XX%. This growth is due to artificial intelligence's effectiveness in the prophecy of the bigotry of the human body toward chemotherapy drugs. Therefore, treatment can be more convenient with a reduction in unnecessary treatments. Similarly, AI helps radiologists automatically recognize complex imaging data and further assessments. Also, the CT segment held the largest share in 2020. The growth is due to precision concerning diagnosing little details of ailment compared to other techniques, far-reaching presence.

By End-user, Diagnostic Facilities Segment to grow at the highest CAGR during the forecast period.

The diagnostic facilities segment is predicted to develop at the fastest CAGR during the projection period. This growth is owing to increasing health consciousness among people. There has been a massive shift in peoples' attitudes from treatment to prevention, fueling the demand for state-of-the-art diagnostic techniques. Moreover, the flow of hard cash has been broadened to outperform currently available facilities. The hospital segment held the largest share in 2020. The growth is owing to the presence of adequate and necessary treatment facilities. On the other hand, prevalent cardiovascular diseases make people rush toward hospitals.

North America to account for the largest market share during the forecast period.

North America held the largest share of Artificial Intelligence in the Medical Diagnostics market in 2020, with a global market share of 36.3%. In North America, the growth in this segment is due to factors such as the top-notch health infrastructure of North American nations like Canada and the US. Presence of world-class educational institutions and scientific research facilities like MIT, CIT, Harvard, Yale, and many more. Moreover, due to high living standards, the population is very health aware.

The Asia Pacific is set to be the fastest-growing over 2021-2026. This growth is due to heightening chronic disorders and a swelling old-age population. Around 10.1% of the Indian population is aging above 65, and the number is anticipated to plunge up to 13-14% by the year 2030. On the other hand, Asian countries have started investing more in research and development facilities ascribing to their prospering economies.

 

Market Dynamics

Driver:  Accruing life-threatening chronic maladies are Anticipated to Boost Product Demand.

Due to the increasing elderly population around the globe, the threat of chronic illnesses has intensified as the body loses its potential to fight maladies with time. China is the most populous country in the world, and, according to a census, around 18.70 % of the population in China is aging above 60. Moreover, India's 10-10.5% population is the 2nd most populous nation after China on planet earth. Therefore, the overall prevalence of chronic illnesses has augmented. The US will have witnessed over 1.9 million cases of cancer in 2021. All these actors, as mentioned above, are anticipated to surge the demand for the respective market.

 

Challenge: Loss of employment due to artificial intelligence is Anticipated to Hamper Market Growth.

There should be no doubt that artificial intelligence in contemporary society is the best thing since sliced bread because no other generation had such convenience that we are enjoying in the 21st century. The only downside is the overdependence of human beings on technology to accomplish tasks. Artificial intelligence can understand and read complex imaging data in no time, finding out intolerance of body toward medical procedure like chemotherapy and associated drugs.

 

Key Market Players

Key Players in the Global Artificial Intelligence in Medical Diagnostics Market consist of AliveCor, Vuno, Aidoc, Siemens Healthineers, Neural Analytics, Zebra Medical Vision, Imagen Technologies, GE Healthcare, IDx Technologies, and Riverain Technologies.

 

Recent Developments:

On November 9, 2021, Israel-based next-generation imaging system manufacturer company "Nanox" acquired "Zebra medical Vision," an imaging company headquartered in central Israel. Nanox paid $110 million to finalize its union with Zebra Medical. The payment of $110 million is made in the form of stock. Moreover, Zebra Medical has been rebranded by Nanox as Nanox.AI.

 

Report Coverage and Scope

The report "Global Artificial Intelligence in Medical Diagnostics Market" by Research Informatic covers an in-depth detailed analysis for the following segment, hidden under the scope.

By Constituent Type

·         Software

·         Hardware

By AI Type

·         Reactive Machines

·         Artificial Narrow Intelligence (ANI)

·         Artificial General Intelligence (AGI)

·         Artificial Super Intelligence (ASI)

·         Others

By Application

·         Diagnosing techniques

o   Ultrasound

o   MRI (= Magnetic Resonance Imaging)

o   CT (= Computed Tomography)

o   X-Ray

·         Diagnosing fields

o   Oncology

o   Ophthalmology

o   Neurology

o   Others

By End-user

·         Hospitals

·         Diagnostic Facilities

·         Research and development Laboratories

By Geography

·         North America

·         Europe

·         APAC

·         RoW

 

 


Chapter 1 Artificial Intelligence in Medical Diagnostics Market Overview


1.1 Product Overview and Scope of Artificial Intelligence in Medical Diagnostics


1.2 Artificial Intelligence in Medical Diagnostics Market Segmentation By Constituent Type


1.2.1 Reactive Machines


1.2.2 Artificial Narrow Intelligence (ANI)


1.2.3 Artificial General Intelligence (AGI)


1.2.4 Artificial Super Intelligence (ASI)


1.2.5 Others


1.3 Artificial Intelligence in Medical Diagnostics Market Segmentation By End User


1.3.1 Hospitals


1.3.2 Diagnostic Facilities


1.3.3 Research and Development Laboratories


1.4 Artificial Intelligence in Medical Diagnostics Market Segmentation by Regions


1.4.1 North America


1.4.2 China


1.4.3 Europe


1.4.4 Southeast Asia


1.4.5 Japan


1.4.6 India


1.5 Global Market Size (Value) of Artificial Intelligence in Medical Diagnostics (2015-2027)


 


Chapter 2 Global Economic Impact on Artificial Intelligence in Medical Diagnostics Industry


2.1 Global Macroeconomic Environment Analysis


2.1.1 Global Macroeconomic Analysis


2.1.2 Global Macroeconomic Environment Development Trend


2.2 Global Macroeconomic Environment Analysis by Regions


 


Chapter 3 Global Artificial Intelligence in Medical Diagnostics Market Competition by Manufacturers


3.1 Global Artificial Intelligence in Medical Diagnostics Production and Share by Manufacturers (2021 and 2021)


3.2 Global Artificial Intelligence in Medical Diagnostics Revenue and Share by Manufacturers (2021 and 2021)


3.3 Global Artificial Intelligence in Medical Diagnostics Average Price by Manufacturers (2021 and 2021)


3.4 Manufacturers Artificial Intelligence in Medical Diagnostics Manufacturing Base Distribution, Production Area and Product Type


3.5 Artificial Intelligence in Medical Diagnostics Market Competitive Situation and Trends


3.5.1 Artificial Intelligence in Medical Diagnostics Market Concentration Rate


3.5.2 Artificial Intelligence in Medical Diagnostics Market Share of Top 3 and Top 5 Manufacturers


3.5.3 Mergers & Acquisitions, Expansion


 


Chapter 4 Global Artificial Intelligence in Medical Diagnostics Production, Revenue (Value) by Region (2015-2021)


4.1 Global Artificial Intelligence in Medical Diagnostics Production by Region (2015-2021)


4.2 Global Artificial Intelligence in Medical Diagnostics Production Market Share by Region (2015-2021)


4.3 Global Artificial Intelligence in Medical Diagnostics Revenue (Value) and Market Share by Region (2015-2021)


4.4 Global Artificial Intelligence in Medical Diagnostics Production, Revenue, Price and Gross Margin (2015-2021)


4.5 North America Artificial Intelligence in Medical Diagnostics Production, Revenue, Price and Gross Margin (2015-2021)


4.6 Europe Artificial Intelligence in Medical Diagnostics Production, Revenue, Price and Gross Margin (2015-2021)


4.7 China Artificial Intelligence in Medical Diagnostics Production, Revenue, Price and Gross Margin (2015-2021)


4.8 Japan Artificial Intelligence in Medical Diagnostics Production, Revenue, Price and Gross Margin (2015-2021)


4.9 Southeast Asia Artificial Intelligence in Medical Diagnostics Production, Revenue, Price and Gross Margin (2015-2021)


4.10 India Artificial Intelligence in Medical Diagnostics Production, Revenue, Price and Gross Margin (2015-2021)


 


Chapter 5 Global Artificial Intelligence in Medical Diagnostics Supply (Production), Consumption, Export, Import by Regions (2015-2021)


5.1 Global Artificial Intelligence in Medical Diagnostics Consumption by Regions (2015-2021)


5.2 North America Artificial Intelligence in Medical Diagnostics Production, Consumption, Export, Import by Regions (2015-2021)


5.3 Europe Artificial Intelligence in Medical Diagnostics Production, Consumption, Export, Import by Regions (2015-2021)


5.4 China Artificial Intelligence in Medical Diagnostics Production, Consumption, Export, Import by Regions (2015-2021)


5.5 Japan Artificial Intelligence in Medical Diagnostics Production, Consumption, Export, Import by Regions (2015-2021)


5.6 Southeast Asia Artificial Intelligence in Medical Diagnostics Production, Consumption, Export, Import by Regions (2015-2021)


5.7 India Artificial Intelligence in Medical Diagnostics Production, Consumption, Export, Import by Regions (2015-2021)


 


Chapter 6 Global Artificial Intelligence in Medical Diagnostics Production, Revenue (Value), Price Trend by Type


6.1 Global Artificial Intelligence in Medical Diagnostics Production and Market Share by Type (2015-2021)


6.2 Global Artificial Intelligence in Medical Diagnostics Revenue and Market Share by Type (2015-2021)


6.3 Global Artificial Intelligence in Medical Diagnostics Price by Type (2015-2021)


6.4 Global Artificial Intelligence in Medical Diagnostics Production Growth by Type (2015-2021)


 


Chapter 7 Global Artificial Intelligence in Medical Diagnostics Market Analysis by Application


7.1 Global Artificial Intelligence in Medical Diagnostics Consumption and Market Share by Application (2015-2021)


7.2 Global Artificial Intelligence in Medical Diagnostics Consumption Growth Rate by Application (2015-2021)


7.3 Market Drivers and Opportunities


7.3.1 Potential Applications


7.3.2 Emerging Markets/Countries


 


Chapter 8 Artificial Intelligence in Medical Diagnostics Manufacturing Cost Analysis


8.1 Artificial Intelligence in Medical Diagnostics Key Raw Materials Analysis


8.1.1 Key Raw Materials


8.1.2 Price Trend of Key Raw Materials


8.1.3 Key Suppliers of Raw Materials


8.1.4 Market Concentration Rate of Raw Materials


8.2 Proportion of Manufacturing Cost Structure


8.2.1 Raw Materials


8.2.2 Labour Cost


8.2.3 Manufacturing Expenses


8.3 Manufacturing Process Analysis of Artificial Intelligence in Medical Diagnostics 


 


Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers


9.1 Artificial Intelligence in Medical Diagnostics Industrial Chain Analysis


9.2 Upstream Raw Materials Sourcing


9.3 Raw Materials Sources of Artificial Intelligence in Medical Diagnostics Major Manufacturers in 2021


9.4 Downstream Buyers


 


Chapter 10 Marketing Strategy Analysis, Distributors/Traders


10.1 Marketing Channel


10.1.1 Direct Marketing


10.1.2 Indirect Marketing


10.1.3 Marketing Channel Development Trend


10.2 Market Positioning


10.2.1 Pricing Strategy


10.2.2 Brand Strategy


10.2.3 Target Client


10.3 Distributors/Traders List


 


Chapter 11 Market Effect Factors Analysis


11.1 Technology Progress/Risk


11.1.1 Substitutes Threat


11.1.2 Technology Progress in Related Industry


11.2 Consumer Needs/Customer Preference Change


11.3 Economic/Political Environmental Change


 


Chapter 12 Global Artificial Intelligence in Medical Diagnostics Market Forecast (2021-2027)


12.1 Global Artificial Intelligence in Medical Diagnostics Production, Revenue Forecast (2021-2027)


12.2 Global Artificial Intelligence in Medical Diagnostics Production, Consumption Forecast by Regions (2021-2027)


12.3 Global Artificial Intelligence in Medical Diagnostics Production Forecast by Type (2021-2027)


12.4 Global Artificial Intelligence in Medical Diagnostics Consumption Forecast by Application (2021-2027)


12.5 Artificial Intelligence in Medical Diagnostics Price Forecast (2021-2027)


 


Chapter 13 Appendix    


 


 


 

Request For Methodology

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any)

Request For List Of Tables

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any)

FAQ

What is the Artificial Intelligence in Medical Diagnostics market share?

The Global Artificial Intelligence in Medical Diagnostics market size is estimated to reach $3,946 million by 2026, growing at a CAGR of 31.7% over the forecast period of 2021-2026.

What are the key factors driving the Artificial Intelligence in Medical Diagnostics Market?

Rising jaw-dropping breakthroughs in technology and elevation in life-threatening chronic disease are factors set to drive the growth of Artificial Intelligence (AI) in the Medical Diagnostics Market.

What are the top companies in the Artificial Intelligence in Medical Diagnostics Market?

AliveCor, Vuno, Aidoc, Siemens Healthineers, Neural Analytics, Zebra Medical Vision, Imagen Technologies, GE Healthcare, IDx Technologies, and Riverain Technologies.

Which region has largest share in Global Artificial Intelligence in Medical Diagnostics Market?

North America held the largest share of Artificial Intelligence in the Medical Diagnostics market in 2020, with a global market share of 36.3%. In North America, the growth in this segment is due to factors such as the top-notch health infrastructure of North American nations like Canada and the US.

Which is the top application segment in the Artificial Intelligence in Medical Diagnostics market?

By Application, the market for Radiology and Oncology segments to grow at the highest CAGR during the forecast period

Choose License Type

Single User

US$ 3500

Multi User

US$ 5250

Corporate User

US$ 7000

Personalize this Research

  • Market Size and Share from 2016 - 2027
  • Expected Market Growth Until 2027
  • COVID-19 Impact assessment on the market
  • Market Dynamics and Impact Analysis
  • Segment and region that will drive or lead the market growth and why
  • Industry activity comprising Mergers, Acquisitions, Expansion, etc.
  • Comprehensive Mapping of the Competitive Landscape
  • In-depth analysis of key sustainability strategies adopted by market players
  • Global and regional market trends – Current and Future
  • Value Chain Analysis
  • Porters Five Forces Analysis
  • Historical and Current Product Pricing
  • Country Cross-Segment Analysis
  • Company Profiling
  • Player Comparison Matrix

Life Science Clients

Artificial Intelligence in Medical Diagnostics Mar...

RD Code : HP22